|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
University Hospital, Ghent University Ghent |
|---|---|
| Information provided by: | University Hospital, Ghent |
| ClinicalTrials.gov Identifier: | NCT00263432 |
Purpose
Implantation of fresh human allogenic chondrocytes in human knee cartilage injuries to obtain a repair and prevention of secondary osteoarthritis
| Condition | Intervention |
|---|---|
|
Cartilage Injuries in the Human Knee |
Procedure: Human allogenic chondrocytes |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
| Official Title: | Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes |
| Estimated Enrollment: | 10 |
| Arms | Assigned Interventions |
|---|---|
|
1: Experimental
Implantation of fresh human allogenic chondrocytes
|
Procedure: Human allogenic chondrocytes
Implantation of fresh human allogenic chondrocytes in human knee cartilage injuries
|
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Karl Fredrik Almqvist, MD, PhD | fredrik.almqvist@UGent.be |
| Belgium | |
| University Hospital Ghent | Recruiting |
| Ghent, Belgium, 9000 | |
| Contact: Karl Fredrik Almqvist, MD, PhD fredrik.almqvist@UGent.be | |
| Principal Investigator: | Karl Fredrik Almqvist, MD, PhD | University Hospital, Ghent |
More Information
| Responsible Party: | University Hospital Ghent ( Karl Fredrik Almqvist, MD, PhD ) |
| Study ID Numbers: | 2001/245 |
| Study First Received: | December 4, 2005 |
| Last Updated: | June 13, 2008 |
| ClinicalTrials.gov Identifier: | NCT00263432 |
| Health Authority: | Belgium: Institutional Review Board |
